102 related articles for article (PubMed ID: 2075087)
1. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
4. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
Tung CC; Chang TC; Su CT; Chen FW; Chang CC
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
[No Abstract] [Full Text] [Related]
6. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
7. [Thyroglobulin, 131I-whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer].
Berding G; Hüfner M; Georgi P
Nuklearmedizin; 1992 Feb; 31(1):32-7. PubMed ID: 1561118
[TBL] [Abstract][Full Text] [Related]
8. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinomas with lung metastases.
Lin JD; Chao TC; Chou SC; Hsueh C
Thyroid; 2004 Dec; 14(12):1091-6. PubMed ID: 15650364
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer.
van Sorge-van Boxtel RA; van Eck-Smit BL; Goslings BM
Nucl Med Commun; 1993 May; 14(5):365-72. PubMed ID: 8510876
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphy with 201Tl for detection of thyroid cancer metastases.
Piers DA; Sluiter WJ; Willemse PH; Doorenbos H
Eur J Nucl Med; 1982; 7(11):515-7. PubMed ID: 7173250
[TBL] [Abstract][Full Text] [Related]
13. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
14. Inactive pulmonary tuberculosis mimicking metastasis from papillary thyroid carcinoma in diagnostic radioiodine whole-body scintigraphy.
Picolos MK; Habra M; Safdar A; Sarlis NJ
Thyroid; 2005 Sep; 15(9):1105-6. PubMed ID: 16187924
[No Abstract] [Full Text] [Related]
15. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
16. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
Miller JH; Marcus CS
Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
[TBL] [Abstract][Full Text] [Related]
17. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
18. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
19. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
20. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
